东方财富网 > 研报大全 > 比亚迪-研报正文
比亚迪-研报正文

Overseas, R&D support 1Q26 earnings resilience

www.eastmoney.com 招银国际 Ji SHI,Wenjing Dou,Austin Liang 查看PDF原文

K图

  比亚迪(002594)

  Maintain BUY.BYD’s1Q26average selling price(ASP)and GPM both beatour prior forecast with overseas contribution,which echoed our previous reporttitled“overseas sales could be a positive surprise in FY26”(link).We expectFY26E GPM to sustain,as we estimate overseas vehicle GPM could be6-8ppts higher than that in China.BYD also becomes more prudent on expenses,especially on R&D,which could provide earnings resilience with highercapitalization ratio.We still believe BYD is one of the biggest beneficiaries fromhigh oil price.

  1Q26revenue,GPM beat on overseas.BYD’s1Q26revenue fell by12%YoY amid a sales volume decline of30%YoY,or13%higher than our priorforecast,as overseas accounted for46%of BYD’s total sales volume in1Q26.That also lifted its GPM by1.4ppts QoQ to18.8%,0.3ppts higherthan our forecast.R&D expenses were more disciplined than we hadprojected while forex loss was higher than expected.All combined resultedin a net profit of RMB4.1bn in1Q26,or about RMB0.7bn higher than ourforecast.

  BYD’s overseas potential could still be underestimated.We estimatethat BYD’s overseas vehicle GPM could be6-8ppts higher than that inChina,based on1Q26and4Q25data with assumptions of minimal QoQchanges in ASPs and GPMs.We maintain our FY26E total sales volumeforecast of5mn units but revise up overseas sales volume by0.1mn unitsto1.6mn units.Accordingly,we raise our FY26E revenue forecast by2%.We also believe higher sales volume from overseas could sustain BYD’sFY26E GPM,despite raw-material price hike and heavy capex.We projectFY26GPM to only narrow by0.1ppt YoY to17.6%.

  R&D capitalization provides earnings resilience.We estimate that R&Dcapitalization ratio rose to about17%in1Q26from9%in FY25,which wasone of the reasons for the net profit beat.As we noted a few times before,BYD’s low R&D capitalization ratios in the past four years have minimizedits amortization burden in the future,which could provide its earningsresilience.We raise its FY26/27E R&D capitalization ratio assumptionsfrom7%/7%to15%/12%.Accordingly,we revise up FY26/27E net profitforecasts by4%/6%to RMB37.9bn/46.3bn.

  Valuation/Key risks.We maintain our BUY rating and A/H share targetprice of HK$125/RMB125,based on22x(prior23x)our FY27E P/E,toreflect the recent market volatility.Key risks to our rating and target priceinclude lower sales volume or margins than we expect,as well as a sectorde-rating.

郑重声明:东方财富发布此内容旨在传播更多的信息,与本站立场无关,不代表东方财富观点。建议用户在阅读研报过程中,请认真仔细阅读研报里的风险提示、免责声明、重要声明等内容,用户据此操作风险自担。

数据来源:东方财富Choice数据

郑重声明:东方财富网发布此信息的目的在于传播更多信息,与本站立场无关。东方财富网不保证该信息(包括但不限于文字、视频、音频、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关信息并未经过本网站证实,不对您构成任何投资建议,据此操作,风险自担。

信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-61278686 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:4000300059/952500